Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banerji, S
Right arrow Articles by Anderson, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banerji, S
Right arrow Articles by Anderson, I.
American Journal of Health-System Pharmacy, Vol 58, Issue 19, 1811-1814
Copyright © 2001 by American Society of Health-System Pharmacists

Articles

Abuse of Coricidin HBP cough & cold tablets: episodes recorded by a poison center

S Banerji and IB Anderson


Cases involving ingestion of a dextromethorphan-containing product recorded at a poison control center were studied. A retrospective review of all consultations involving the ingestion of Coricidin HBP Cough & Cold tablets recorded by the California Poison Control System was conducted for the period from January 1 to October 1, 2000. Computerized charts on the consultations were reviewed to obtain data on patient age and sex, number of tablets taken, reason for tablet ingestion, symptoms, treatment, disposition, and outcome. A total of 92 charts (for 92 patients) documenting Coricidin HBP Cough & Cold tablet ingestion were reviewed. The reason for tablet ingestion was classified as abuse in 65 patients (71%), a suicide attempt in 8 (9%), misuse in 1 (1%), malicious administration in 1 (1%), and normal use (but with an adverse drug reaction) in 1 (1%); 16 patients (17%) consumed the tablets for an unknown reason. The 92 patients comprised 42 males and 50 females. Among all patients, 78 (85%) were 13-17 years old, and among those classified as having abusive intent, 58 (89%) were in the same age range. The most commonly reported signs and symptoms associated with ingestion were tachycardia (50 patients), hypertension (29), lethargy (40), mydriasis (20), agitation (15), ataxia or dizziness (20), and vomiting (9). Sixty-one patients (66%) had some alteration in mental status. Fifty-six (61%) were treated in the emergency department; 11 (12%) were admitted. All patients recovered completely. Information on the ingestion of Coricidin HBP Cough & Cold tablets recorded at a poison control center indicated a high rate of abuse of the product among teenagers.
 



This article has been cited by other articles:


Home page
 Arch Pediatr Adolesc MedHome page
J. K. Bryner, U. K. Wang, J. W. Hui, M. Bedodo, C. MacDougall, and I. B. Anderson
Dextromethorphan Abuse in Adolescence: An Increasing Trend: 1999-2004
Arch Pediatr Adolesc Med, December 1, 2006; 160(12): 1217 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
R. H. Schwartz
Adolescent Abuse of Dextromethorphan
Clinical Pediatrics, September 1, 2005; 44(7): 565 - 568.
[Abstract] [PDF]

Home page
 The Annals of PharmacotherapyHome page
A. Sharma, V. Dewan, and F. Petty
Acute psychosis with Coricidin cold medicine
Ann. Pharmacother., September 1, 2005; 39(9): 1577 - 1578.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Health-System Pharmacists.